The CE marking clears the way for the company to market its PET system across the EU after launching in the US market in July ...

GE HealthCare has secured the FDA’s approval for an injectable, radioactive imaging agent that gives clinicians a clearer ...

Positrigo, a Swiss based company developing nuclear medical imaging devices to advance functional brain imaging, has achieved ...

New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported in July. But ...

Alzheimer's disease is a brain disorder that destroys memory and thinking skills. Early symptoms include difficulty ...

The tests will measure blood-based tau markers, offering a possible alternative to PET imaging for aiding in diagnosis and staging of Alzheimer's disease.

We spoke to Andrew Doig, professor of biochemistry at the University of Manchester, to find out more about the evolving ...

There is an urgent need to improve access to new innovations in the diagnosis and treatment of Alzheimer's disease. Embracing breakthroughs such as blood-based biomarker testing, has the potential to ...

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...